Epogen Side Effects

Generic name: epoetin alfa

Medically reviewed by Drugs.com. Last updated on Aug 29, 2024.

Note: This document provides detailed information about Epogen Side Effects associated with epoetin alfa. Some dosage forms listed on this page may not apply specifically to the brand name Epogen.

Applies to epoetin alfa: injection solution.

Important warnings This medicine can cause some serious health issues

Injection route (solution)

ESAs increase the risk of death, myocardial infarction, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence.Chronic Kidney Disease:In controlled trials, patients experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level greater than 11 g/dL.No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks.Use the lowest epoetin alfa-epbx dose sufficient to reduce the need for red blood cell (RBC) transfusions.Cancer:ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers.To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions.Use ESAs only for anemia from myelosuppressive chemotherapy.ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure.Discontinue following the completion of a chemotherapy course.Perisurgery:Due to increased risk of deep venous thrombosis (DVT), DVT prophylaxis is recommended.

Serious side effects of Epogen

Along with its needed effects, epoetin alfa (the active ingredient contained in Epogen) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking epoetin alfa:

More common side effects

• black, tarry stools
• blurred vision
• body aches or pain
• bone pain
• chest pain
• chills
• cough
• dizziness
• dry mouth
• ear congestion
• fever
• flushed, dry skin
• fruit-like breath odor
• headache
• increased hunger
• increased thirst
• increased urination
• itching, skin rash
• loss of voice
• nausea
• nervousness
• pain, redness, or swelling in the arm or leg
• painful or difficult urination
• pounding in the ears
• runny or stuffy nose
• slow or fast heartbeat
• sneezing
• sore throat
• sores, ulcers, or white spots on the lips or in the mouth
• stomach pain
• swollen glands
• tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area
• trouble breathing
• unexplained weight loss
• unusual bleeding or bruising
• unusual tiredness or weakness
• vomiting

Less common side effects

• anxiety
• decreased urine
• difficulty swallowing
• fainting
• irregular heartbeat
• loss of appetite
• mood changes
• muscle pain or cramps
• numbness or tingling in the hands, feet, or lips
• seizures
• swelling

Incidence not known

• blistering, peeling, or loosening of the skin
• dark urine
• diarrhea
• fluid-filled skin blisters
• hives
• joint pain
• light-colored stools
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• red skin lesions, often with a purple center
• red, irritated eyes
• sensitivity to the sun
• skin thinness
• tightness in the chest
• yellow eyes or skin

Other side effects of Epogen

Some side effects of epoetin alfa may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• decreased weight
• difficulty in moving
• injection site irritation or pain
• muscle spasm or stiffness
• swelling or inflammation of the mouth
• swollen joints
• trouble sleeping

Less common side effects

• discouragement
• feeling sad or empty
• irritability
• loss of interest or pleasure
• trouble concentrating

For healthcare professionals

Applies to epoetin alfa: injectable solution.

General adverse events

The most common adverse reaction was dose-dependent increase in blood pressure or aggravation of existing hypertension.^[Ref]

Gastrointestinal

• Very common (10% or more): Nausea (up to 56%), diarrhea (up to 30%), vomiting (up to 28%), stomatitis (10%)
• Common (1% to 10%): Dysphagia
• Frequency not reported: Vomiting^[Ref]

Other

• Very common (10% or more): Pyrexia (up to 42%)
• Common (1% to 10%): Chills, influenza-like illness, peripheral edema, artificial kidney clotting during dialysis, edema^[Ref]

Nervous system

• Very common (10% or more): Headache (up to 34%)
• Common (1% to 10%): Convulsion, dizziness
• Frequency not reported: Cerebrovascular accident, transient ischemic attack^[Ref]

Cardiovascular

• Very common (10% or more): Hypertension (up to 33%), embolism and thrombosis (up to 15%)
• Common (1% to 10%): Deep vein thrombosis, thrombosis
• Uncommon (0.1% to 1%): Myocardial infarction
• Frequency not reported: Blood pressure increased, aneurysm^[Ref]

Respiratory

• Very common (10% or more): Cough (up to 26%)
• Common (1% to 10%): Respiratory tract congestion, upper respiratory tract infection, pulmonary embolism^[Ref]

Dermatologic

• Very common (10% or more): Rash (up to 25%), pruritus (up to 21%)
• Common (1% to 10%): Urticaria
• Uncommon (0.1% to 1%): Erythema
• Frequency not reported: Angioedema
• Postmarketing reports: Severe cutaneous reactions^[Ref]

Musculoskeletal

• Very common (10% or more): Arthralgia (up to 24%), pain in extremity (up to 15%), myalgia (up to 10%)
• Common (1% to 10%): Bone pain, muscle spasm
• Frequency not reported: Porphyria^[Ref]

Local

• Very common (10% or more): Injection site reaction (up to 18%), injection site pain (up to 13%)
• Common (1% to 10%): Vascular access thrombosis^[Ref]

Metabolic

• Very common (10% or more): Hyperkalemia (up to 10%)
• Common (1% to 10%): Weight decrease, hyperglycemia, hypokalemia^[Ref]

Psychiatric

• Common (1% to 10%): Insomnia, depression^[Ref]

Hematologic

• Common (1% to 10%): Leukopenia
• Postmarketing reports: Erythropoietin antibody-mediated pure red cell aplasia, thrombocytopenia^[Ref]

Immunologic

• Frequency not reported: Anaphylactic reaction, hypersensitivity
• Postmarketing reports: Serious allergic reaction^[Ref]

Frequently asked questions

• What are biosimilar drugs and how do they compare to biologics?
• What biosimilars have been approved in the United States?
• What is the difference between Retacrit and Epogen?

Further information

Epogen side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer